Clinical Trial Update: Sugammadex Versus Neostigmine for Reversal of Rocuronium Neuromuscular [Phase 4]

View source ↗

Summary

Phase 4 trial comparing sugammadex to neostigmine for reversal of rocuronium-induced neuromuscular blockade completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anesthesia
• Neuromuscular Blockade

Drugs mentioned

• Neostigmine (neostigmine)
• Sugammadex (sugammadex)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Neuromuscular Blockade, Anesthesia | Phase 4 | Status: COMPLETED | Results posted: 2021-04-08